Using longitudinal imaging to map the 'relapse signature' of schizophrenia and other psychoses

Epidemiology and Psychiatric Sciences

Volumn 23, Issue 3, 2014, Pages 219-225

  Cropley, V L ^a   Pantelis, C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Biomarkers; brain trajectories; inflammation; neurodevelopment; neuroimaging; psychosis relapse; psychosis remission

Indexed keywords

BIOLOGICAL MARKER; N ACETYLASPARTIC ACID;

BRAIN; BRAIN MAPPING; BRAIN SIZE; DISEASE COURSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN GENETICS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; LIFESTYLE; LONGITUDINAL STUDY; MENTAL DISEASE; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PSYCHOSIS; RELAPSE; REMISSION; REVIEW; SCHIZOPHRENIA; STRESS; SUBSTANCE USE;

EID: 84904855055     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796014000341     Document Type: Review

References (37)

1. Bodnar M, Achim AM, Malla AK, Joober R, Benoit A, Lepage M (2012). Functional magnetic resonance imaging correlates of memo ry encoding in relation to achieving remission in first-episode schizophrenia. British Journal of Psychiatry 200, 300-307.
2. Bustillo JR, Rowland LM, Jung R, Brooks WM, Qualls C, Hammond R, Hart B, Lauriello J (2008). Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia. Neuropsychopharmacology 33, 2456-2466.
3. Cahn W, Rais M, Stigter FP, Va n Haren NE, Caspers E, Hulshoff Pol HE, Xu Z, Schnack HG, Kahn RS (2009). Psychosis and brain volume changes during the first five years of schizophrenia. European Neuropsychopharmacology 19, 147-151.
4. Cropley V, Wood SJ, Pantelis C (2013). Brain structural, neurochemical and neuroinflammatory markers of psychosis onset and relapse: Is there evidence for a psychosis relapse signature? International Clinical Psychopharmacology, 10 Ma y [Epub ahead of print].
5. Egerton A, Brugger S, Raffin M, Barker GJ, Lythgoe DJ, Mcguire PK, Stone JM (2012). Anterior cingulate glutamate levels related to clinical status following treatment in first-episo De schizophrenia. Neuropsychopharmacology 37, 2515-2521.
6. Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B, Brewer WJ, Smith DJ, Dazzan P, Berger GE, Yung AR, Va n Den Buuse M, Murray R, Mcgorry PD, Pantelis C (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry 58, 417-423.
7. Garver DL, Nair TR, Christensen JD, Holcomb JA, Kingsbury SJ (2000). Brain and ventricle instability during psychotic episodes of the schizophrenias. Schizophrenia Research 44, 11-23.
8. Gogtay N (2008). Cortical brain development in schizophrenia: Insights from neuroimaging studies in childhood-onset schizophrenia. Schizophrenia Bulletin 34, 30-36.
9. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Gr eenstein D, Vaituzis AC, Nugent III TF, Herman DH, Clasen LS, Toga AW, Rapoport JL, Thompson PM (2004). Dynamic mapping of human cortical development during childhood through early adulthood. Proceeding of the Nat ional Academy of Sciences USA 101, 8174-8179.
10. Gogtay N, Lu A, Leow AD, Klunder AD, Lee AD, Chavez A, Greenstein D, Giedd JN, Toga AW, Rapoport JL, Thompson PM (2008). Three-dimensi onal brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry. Proceeding of the National Academy of Sciences USA 105, 15979-15984.
11. Gogtay N, Vyas NS, Testa R, Woo d SJ, Pantelis C (2011). Age of onset of schizophrenia: Perspectives from structural neuroimaging studies. Schizophrenia Bulletin 37, 504-513.
12. Greenstein D, Lerch J, Shaw P, Clasen L, Giedd J, G ochman P, Rapoport J, Gogtay N (2006). Childhood onset schizophrenia: Cortical brain abnormalities as young adults. Journal of Child Psychology and Psychiatry 47, 1003-1012.
13. Gur RE, Cowell P, Turets ky BI, Gallacher F, Cannon T, Bilker W, Gur RC (1998). A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Archives of General Psych iatry 55, 145-152.
14. Kraguljac NV, Reid M, White D, Jones R, Den Hollander J, Lowman D, Lahti AC (2012). Neurometabolites in schizophrenia and bipolar disorder-A systematic review and meta-analysis. Psychiatry Research 203, 111-125.
15. Lenroot RK, Giedd JN (2006). Brain development in children and adolescents: Insights from anatomical magnetic resonance imaging. Neuroscience and Biobehavioral Reviews 30, 718-729.
16. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J (2001). The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology, and therapeutic approa ches. Biological Psychiatry 50, 884-897.
17. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A (2001). Progressive brain volume changes and the clinical course of schizophrenia in men: A longitudinal magnetic resonance imaging study. Archives of General Psychiatry 58, 148-157.
18. Mitelman SA, Canfield EL, Chu KW, Brickman AM, Shihabuddin L, Hazlett EA, Buchsbaum MS (2009). Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen. Schizophrenia Research 113, 241-245.
19. Pantelis C, Bartholomeusz C (in press). Social neuroscience in psychiatry: Pathways to discovering neurobiological risk and resilience (invited commentary). World Psychiatry Pantelis C, Wood SJ (2009). Imaging in schizophrenia: Looking back and peering ahead. Annals of Academy of Medicine Singapore 38, 440-442.
20. Pantelis C, Yucel M, Bora E, Fornito A, Testa R, Brewer WJ, Velakoulis D, Wood SJ (2009). Neurobiological markers of illness onset in psychosis and schizophrenia: The search for a moving target. Neuropsych ology Review 19, 385-398.
21. Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, Nicolson R, Bedwell J, Lenane M, Zijdenbos A, Paus T, Evans A (1999). Prog ressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Archives of General Psychiatry 56, 649-654.
22. Shaw P, Kabani NJ, Lerch JP, Eckstrand K, Lenroot R, Gogtay N, Greenstein D, Clasen L, Evans A, Rapoport JL, Giedd JN, Wise SP (2008). Neurodevelopmental trajectories of the human cerebral cortex. Journal of Neuroscience 28, 3586-3594.
23. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, Mcguire PK, Riecher-Rossler A, Borgwardt SJ (2010). Neuroimaging predictors of transition to psychosis-A systematic revi ew and meta-analysis. Neuroscience and Biobehavioral Reviews 34, 1207-1222.
24. Sun D, Phillips L, Velakoulis D, Yung A, Mcgorry PD, Wood SJ, Van Erp TG, Thompson PM, Toga AW, Cannon TD, Pantelis C (2009 a). Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophrenia Research 108, 85-92.
25. Sun D, Stuart GW, Jenkinson M, Wood SJ, Mcgorry PD, Velakoulis D, Van Erp TG, Thompson PM, Toga AW, Smith DJ, Cannon TD, Pantelis C (2009 b ). Brain surface contraction mapped in first-episode schizophrenia: A longitudinal magnetic resonance imaging study. Molecular Psychiatry 14, 976-986.
26. Takahashi T Wood SJ Soulsby B Kawasaki Y Mcgorry PD Suzuki M Velakoulis D Pantelis C 2009 An MRI study of the superior temporal subregions in first-episode patients with various psychotic disorders Schizophrenia Research 113 158-166.
27. Takahashi T, Wood SJ, Soulsby B, Mcgorry PD, Tanino R, Suzuki M, Velakoulis D, Pantelis C (2009b ). Follow- upMRI study of the insular cortex in first-episode psychosis and chronic schizophrenia. Schizophrenia Research 108, 49-56.
28. Takahashi T,Wood SJ, Soulsby B, Tanino R,Wong MT, Mcgorry PD, Suzuki M, Velakoulis D, Pantelis C (2009 c ). Diagnostic specificity of the insular cortex abnormalities in first-episode psychotic disorders. Progress in Neuropsychopharmacological andBiologicalPsychiatry 33, 651-657.
29. Takahashi T , Wood SJ, Yung AR, Phillips LJ, Soulsby B, Mcgorry PD, Tanino R, Zhou SY, Suzuki M, Velakoulis D, Pantelis C (2009d). Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosi s. Schizophrenia Research 111, 94-102.
30. Takahashi T, Wood SJ, Yung AR, Soulsby B, Mcgorry PD, Suzuki M, Kawasaki Y, Phillips LJ, Velakoulis D, Pantelis C (2009e). Progressive gray matt er reduction of the superior temporal gyrus during transition to psychosis. Archives of General Psychiatry 66, 366-376.
31. Takahashi T, Suzuki M, Zhou SY, Tanino R, Nakamura K, Kawasaki Y, Seto H, K urachi M (2010a). A follow-up MRI study of the superior temporal subregions in schizotypal disorder and first-episode schizophrenia. Schizophrenia Research 119, 65-74.
32. Takahashi T, Wood SJ, Kawasaki Y, Suzuki M, Velakoulis D, Pantelis C (2010b). Lack of progressive gray matter reduction of the superior temporal subregions in chronic schizophrenia. Schizophrenia Research 117, 101-102.
33. Takahashi T,Wood SJ, Yung AR,Walterfang M, Phillips LJ, Soulsby B, Kawasaki Y, Mcgorry PD, Suzuki M, Velakoulis D, Pantelis C (2010c). Superior temporal gyrus volume in antipsychotic-naive people at risk of psychosis. British Journal of Psychiatry 196, 206-211.
34. Testa R, Pantelis C (2009). The role of executive functions in psychiatric disorders. In The Neuropsychology of Mental Illness (ed. SJ Wood, NJ Allen and C Pantelis). Cambridge University Press: Cambridge.
35. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, Toga AW, Rapoport JL (2001). Mapping adolescent brain c hange reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proceeding of the National Academy of Sciences USA 98, 11650-11655.
36. Urban N, Abi-Dargham A (2010). Neurochemical imaging in schizophrenia. Current Topics in Behavioral Neuroscience 4, 215-242.
37. Wood SJ, Pantelis C, Yung AR, Velakoulis D, Mcgorry PD (2009). Brain changes during the onset of schizophrenia: Implications for neurodevelopmental theories. Medical Journal of Australia 190, S10-S13.